Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ: INCY )

58.00 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39
Open 58.00
Bid (Size) 50.00 (1)
Ask (Size) 77.00 (1)
Prev. Close 58.00
Today's Range 58.00 - 58.00
52wk Range 50.35 - 83.95
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
From Incyte
Via Business Wire
INCYTE CORP (NASDAQ:INCY) is probably undervalued for the fundamentals it is displaying.
Take a closer look at INCYTE CORP , a remarkable value stock. NASDAQ:INCY excels in fundamentals and maintains a very reasonable valuation. 
Via Chartmill

Performance

YTD
-16.58%
-16.58%
1 Month
-7.58%
-7.58%
3 Month
-19.90%
-19.90%
6 Month
-11.00%
-11.00%
1 Year
+12.29%
+12.29%

More News

Read More
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Incyte to Report First Quarter Financial Results
From Incyte
Via Business Wire
What's going on in today's session: S&P500 movers
Via Chartmill
These S&P500 stocks are gapping in today's session
Via Chartmill
Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday?
Via Benzinga
Topics World Trade
Exposures Tariff
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Which S&P500 stocks are gapping on Tuesday?
Via Chartmill
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Incyte
Via Business Wire
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Meta, AMD, Apple, AT&T Among Biggest US Tech Giants That 'May Suffer The Most' As Tariffs Spark Trade Turmoil: Here's Why
Via Benzinga
3 Reasons INCY is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures US Equities
XPeng, Reddit And Micron Tech Are Among Top 10 Large-Cap Losers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
Via Benzinga
What's going on in today's session: S&P500 movers
Via Chartmill
Why Incyte Stock Was Tanking This Week
Via The Motley Fool
1 Healthcare Stock on Our Watchlist and 2 to Brush Off
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tesla To $320? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
What's going on in today's after hours session: S&P500 movers
Via Chartmill
Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Why Incyte (INCY) Stock Is Nosediving
Via StockStory
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.